Bank of New York Mellon’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-137,886
| Closed | -$6.62M | – | 4221 |
|
|
2020
Q1 | $6.62M | Sell |
137,886
-1,102
| -0.8% | -$52.9K | ﹤0.01% | 1923 |
|
|
2019
Q4 | $6.52M | Sell |
138,988
-30,514
| -18% | -$1.43M | ﹤0.01% | 2201 |
|
|
2019
Q3 | $4.01M | Buy |
169,502
+11,302
| +7% | +$267K | ﹤0.01% | 2390 |
|
|
2019
Q2 | $4.76M | Buy |
158,200
+19,785
| +14% | +$595K | ﹤0.01% | 2355 |
|
|
2019
Q1 | $3.1M | Buy |
138,415
+60,597
| +78% | +$1.36M | ﹤0.01% | 2561 |
|
|
2018
Q4 | $1.42M | Buy |
77,818
+24,059
| +45% | +$438K | ﹤0.01% | 2908 |
|
|
2018
Q3 | $973K | Buy |
53,759
+5,797
| +12% | +$105K | ﹤0.01% | 3271 |
|
|
2018
Q2 | $478K | Sell |
47,962
-3,864
| -7% | -$38.5K | ﹤0.01% | 3649 |
|
|
2018
Q1 | $275K | Buy |
51,826
+14,383
| +38% | +$76.3K | ﹤0.01% | 3820 |
|
|
2017
Q4 | $318K | Buy |
37,443
+358
| +1% | +$3.04K | ﹤0.01% | 3766 |
|
|
2017
Q3 | $542K | Sell |
37,085
-847
| -2% | -$12.4K | ﹤0.01% | 3550 |
|
|
2017
Q2 | $711K | Buy |
37,932
+13,881
| +58% | +$260K | ﹤0.01% | 3435 |
|
|
2017
Q1 | $512K | Buy |
24,051
+10,493
| +77% | +$223K | ﹤0.01% | 3544 |
|
|
2016
Q4 | $206K | Buy |
+13,558
| New | +$206K | ﹤0.01% | 3896 |
|